Capital International Sarl’s Ascendis Pharma A/S ASND Stock Holding History

Capital International Sarl’s Portfolio ASND Stock Details ASND Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$6.99M	Buy	26,222 +1,473	+6%	+$344K	0.1%	136
2026 Q1	$5.66M	Sell	24,749 -194	-0.8%	-$43.5K	0.09%	141
2025 Q4	$5.32M	Sell	24,943 -5,919	-19%	-$1.22M	0.09%	148
2025 Q3	$6.14M	Buy	30,862 +2,701	+10%	+$504K	0.11%	137
2025 Q2	$4.86M	Buy	28,161 +2,779	+11%	+$453K	0.09%	145
2025 Q1	$3.96M	Buy	25,382 +1,576	+7%	+$225K	0.09%	152
2024 Q4	$3.28M	Buy	+23,806	New	+$3.13M	0.08%	152

Other funds holding ASND

RCM

RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return

Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return

Jupiter Topco New York $245B AUM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Capital International Sarl's ASND Position: Q2 2026 in Review

Capital International Sarl increased its Ascendis Pharma A/S (ASND) stake by 6% in Q2 2026, buying an estimated $344K and bringing the position to 26,222 shares worth $6.99M. The position accounts for 0.1% of the portfolio, ranked #136.

Capital International Sarl first reported a position in ASND in Q4 2024 and has held it in 7 quarters since. 313 funds tracked by Wall St. Rank hold ASND as of Q2 2026.

Capital International Sarl held 26,222 shares of Ascendis Pharma A/S worth $6.99M as of Q2 2026.
Capital International Sarl bought 1,473 Ascendis Pharma A/S shares in Q2 2026, an estimated $344K.
Ascendis Pharma A/S made up 0.1% of Capital International Sarl's portfolio in Q2 2026, its #136 holding.
Capital International Sarl first reported a position in Ascendis Pharma A/S in Q4 2024 and has held it in 7 quarters since.
313 funds tracked by Wall St. Rank held Ascendis Pharma A/S as of Q2 2026.

Based on Capital International Sarl's 13F filing for Q2 2026, filed 12 Aug 2026.